Results 371 to 380 of about 9,546,669 (393)
Some of the next articles are maybe not open access.

Combination Antimicrobial Therapy

Pediatric Clinics of North America, 1983
In spite of a large volume of data regarding the in vitro activity of single and combined antimicrobial activity, the clinical relevance of these studies is unclear. Few comparative trials of combined and single antibiotic therapy of human infection have been performed.
David M. Shlaes, Steven N. Bass
openaire   +3 more sources

Combination Therapy in Hypertension

Current Cardiovascular Risk Reports, 2012
Arterial hypertension is the most important modifiable cardiovascular risk factor leading to death in general population. Optimal treatment strategies are continuously being debated and both the initiation and maintenance of a pharmacologic approach have been evaluated in the latest clinical trials.
SOLINI, ANNA   +2 more
openaire   +2 more sources

Combined Therapies in OCD

Journal of Psychosocial Nursing and Mental Health Services, 1996
Helping the patient maintain independence after professional community support has been discontinued was a primary objective from the initial treatment planning.
openaire   +3 more sources

Staphylococci and Combination Therapy

Archives of Internal Medicine, 1979
Optimal antimicrobial therapy for severe infections " caused byStaphylococcus aureus, ie, bacteremia or endocarditis, is currently controversial. In this issue of theArchives(see p 1094), data are presented that address one aspect of this extremely important problem. The major thrust of the reported observations suggests that the serum of most patients
openaire   +3 more sources

The rationale for combination therapy

The American Journal of Cardiology, 2002
The use of combination lipid-altering therapy for dyslipidemia is becoming increasingly important for effective management of patients with coronary heart disease (CHD). In accordance with the Adult Treatment Panel III guidelines, the primary target of therapy is lowering low-density lipoprotein (LDL) cholesterol.
openaire   +3 more sources

Combination Bronchodilator Therapy

Drugs, 1982
Bronchodilators may be classified into 3 groups: anticholinergics, beta-adrenoceptor agonists and methylxanthines. These drugs act through related biochemical pathways and there are theoretical reasons for expecting beneficial additive or synergistic interactions between them.
openaire   +2 more sources

Rationale for combined therapy

Cancer, 1977
The presence of micrometastatic disease at the time of diagnosis is the major cause of failure in the treatment of cancer. The mechanisms, biology, and biochemistry of tumor metastases at an experimental level are being effectively studied. Potential control points and therapeutic implications are emerging.
openaire   +3 more sources

Combination Therapy for Invasive Fungal Infections

Current Fungal Infection Reports, 2020
Spencer J. Livengood   +2 more
semanticscholar   +1 more source

Combination Therapy

Archives of Internal Medicine, 1971
openaire   +2 more sources

Combination therapy

Nanocarriers for the Delivery of Combination Drugs, 2021
M. K. Iqubal   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy